Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization

Journal of Leukocyte Biology

Volumn 90, Issue 4, 2011, Pages 717-726

  Romo, Neus ^a   Magri, Giuliana ^a   Muntasell, Aura ^b   Heredia, Gemma ^a   Baía, Diogo ^a   Angulo, Ana ^c   Guma, Monica ^a,b   López Botet, Miguel ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

2B4 (CD244); CD48; Cytokine; DNAM 1 (cd226); Interferon; Natural cytotoxicity receptor (NCR)

Indexed keywords

ALPHA INTERFERON; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY MACROPHAGE; ARTICLE; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROINFLAMMATORY MACROPHAGE;

CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MACROPHAGES; MONOKINES; TIME FACTORS;

HUMAN HERPESVIRUS 5;

EID: 80053350424     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0311171     Document Type: Article

References (49)

1. Mocarski, E. S., Courcelle, C. T. (2006) Cytomegaloviruses and their replicaton. In: Fields Virology (D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, eds.), Lippincott Williams & Wilkins, Philadelphia, 2629-2673.
2. Liu, R., Moroi, M., Yamamoto, M., Kubota, T., Ono, T., Funatsu, A., Komatsu, H., Tsuji, T., Hara, H., Hara, H., Nakamura, M., Hirai, H., Yamaguchi, T. (2006) Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int. Heart J. 47, 511-519.
3. Söderberg-Nauclér, C. (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J. Intern. Med. 259, 219-246.
4. Smith, M. S., Bentz, G. L., Alexander, J. S., Yurochko, A. D. (2004) Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78, 4444-4453.
5. Gerna, G., Zipeto, D., Percivalle, E., Parea, M., Revello, M. G., Maccario, R., Peri, G., Milanesi, G. (1992) Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J. Infect. Dis. 166, 1236-1244.
6. Söderberg-Nauclér, C., Fish, K. N., Nelson, J. A. (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119-126.
7. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
8. Goerdt, S., Orfanos, C. E. (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142.
9. Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
10. Verreck, F. A., de Boer, T., Langenberg, D. M., van der Zanden, L., Ottenhoff, T. H. (2006) Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulation. J. Leukoc. Biol. 79, 285-293.
11. Martinez, F. O., Sica, A., Mantovani, A., Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461.
12. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
13. Blumenthal, R. L., Campbell, D. E., Hwang, P., DeKruyff, R. H., Frankel, L. R., Umetsu, D. T. (2001) Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. J. Allergy Clin. Immunol. 107, 258-264.
14. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549 -555.
15. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B., Doni, A., Vincenzo, B., Pasqualini, F., Vago, L., Nebuloni, M., Mantovani, A., Sica, A. (2006) A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122.
16. Szekanecz, Z., Koch, A. E. (2007) Macrophages and their products in rheumatoid arthritis. Curr. Opin. Rheumatol. 19, 289-295.
17. Zhang, X., Mosser, D. M. (2008) Macrophage activation by endogenous danger signals. J. Pathol. 214, 161-178.
18. Sinzger, C., Eberhardt, K., Cavignac, Y., Weinstock, C., Kessler, T., Jahn, G., Davignon, J. L. (2006) Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules. J. Gen. Virol. 87, 1853-1862.
19. Frascaroli, G., Varani, S., Blankenhorn, N., Pretsch, R., Bacher, M., Leng, L., Bucala, R., Landini, M. P., Mertens, T. (2009) Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J. Immunol. 182, 477-488.
20. Strååt, K., de Klark, R., Gredmark-Russ, S., Eriksson, P., Soderberg-Naucler, C. (2009) Infection with human cytomegalovirus alters the MMP-9/ TIMP-1 balance in human macrophages. J. Virol. 83, 830-835.
21. Chan, G., Bivins-Smith, E. R., Smith, M. S., Smith, P. M., Yurochko, A. D. (2008) Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 181, 698-711.
22. Chan, G., Bivins-Smith, E. R., Smith, M. S., Yurochko, A. D. (2009) NF-B and phosphatidylinositol 3-kinase activity mediates the HCMVinduced atypical M1/M2 polarization of monocytes. Virus Res. 144, 329-333.
23. Biron, C. A., Brossay, L. (2001) NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13, 458-464.
24. Yewdell, J. W., Hill, A. B. (2002) Viral interference with antigen presentation. Nat. Immunol. 3, 1019-1025.
25. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., Wilkinson, G. W. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287, 1031.
26. Chalupny, N. J., Rein-Weston, A., Dosch, S., Cosman, D. (2006) Downregulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem. Biophys. Res. Commun. 346, 175-181.
27. Dunn, C., Chalupny, N. J., Sutherland, C. L., Dosch, S., Sivakumar, P. V., Johnson, D. C., Cosman, D. (2003) Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 197, 1427-1439.
28. Tomasec, P., Wang, E. C., Davison, A. J., Vojtesek, B., Armstrong, M., Griffin, C., McSharry, B. P., Morris, R. J., Llewellyn-Lacey, S., Rickards, C., Nomoto, A., Sinzger, C., Wilkinson, G. W. (2005) Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 6, 181-188.
29. Magri, G., Muntasell, A., Romo, N., Saez-Borderias, A., Pende, D., Geraghty, D. E., Hengel, H., Angulo, A., Moretta, A., Lopez-Botet, M. (2011) NKp46 and DNAM-1 NK cell receptors drive the response to human cytomegalovirus infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117, 848-856.
30. Pende, D., Castriconi, R., Romagnani, P., Spaggiari, G. M., Marcenaro, S., Dondero, A., Lazzeri, E., Lasagni, L., Martini, S., Rivera, P., Capobianco, A., Moretta, L., Moretta, A., Bottino, C. (2006) Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 107, 2030-2036.
31. Sierra-Filardi, E., Puig-Kroger, A., Blanco, F. J., Nieto, C., Bragado, R., Palomero, M. I., Bernabeu, C., Vega, M. A., Corbi, A. L. (2011) Activin A skews macrophage polarization by promoting a pro-inflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117, 5092-5101.
32. Prod'homme, V., Sugrue, D. M., Stanton, R. J., Nomoto, A., Davies, J., Rickards, C. R., Cochrane, D., Moore, M., Wilkinson, G. W., Tomasec, P. (2010) Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112. J. Gen. Virol. 91, 2034-2039.
33. Morandi, B., Costa, R., Falco, M., Parolini, S., De Maria, A., Ratto, G., Mingari, M. C., Melioli, G., Moretta, A., Ferlazzo, G. (2005) Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. J. Immunol. 175, 3690-3697.
34. Verreck, F. A., de Boer, T., Langenberg, D. M., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., Ottenhoff, T. H. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101, 4560-4565.
35. Hargett, D., Shenk, T. E. (2010) Experimental human cytomegalovirus latency in CD14+ monocytes. Proc. Natl. Acad. Sci. USA 107, 20039-20044.
36. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., Moretta, L. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223.
37. Endt, J., Eissmann, P., Hoffmann, S. C., Meinke, S., Giese, T., Watzl, C. (2007) Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells. Eur. J. Immunol. 37, 193-198.
38. Bellora, F., Castriconi, R., Dondero, A., Reggiardo, G., Moretta, L., Mantovani, A., Moretta, A., Bottino, C. (2010) The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc. Natl. Acad. Sci. USA 107, 21659-21664.
39. Nedvetzki, S., Sowinski, S., Eagle, R. A., Harris, J., Vely, F., Pende, D., Trowsdale, J., Vivier, E., Gordon, S., Davis, D. M. (2007) Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 109, 3776-3785.
40. Muntasell, A., Magri, G., Pende, D., Angulo, A., Lopez-Botet, M. (2010) Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection. Blood 115, 5170-5179.
41. Odeberg, J., Cerboni, C., Browne, H., Karre, K., Moller, E., Carbone, E., Soderberg-Naucler, C. (2002) Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand. J. Immunol. 55, 149-161.
42. Robson, N. C., Wei, H., McAlpine, T., Kirkpatrick, N., Cebon, J., Maraskovsky, E. (2009) Activin-A attenuates several human natural killer cell functions. Blood 113, 3218-3225.
43. Nathan, C. F., Murray, H. W., Wiebe, M. E., Rubin, B. Y. (1983) Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670-689.
44. Billiau, A., Matthys, P. (2009) Interferon-γ: a historical perspective. Cytokine Growth Factor Rev. 20, 97-113.
45. Agnello, D., Lankford, C. S., Bream, J., Morinobu, A., Gadina, M., O'Shea, J. J., Frucht, D. M. (2003) Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23, 147-161.
46. Sainz Jr., B., LaMarca, H. L., Garry, R. F., Morris, C. A. (2005) Synergistic inhibition of human cytomegalovirus replication by interferon-α/β and interferon-γ. Virol. J. 2, 14.
47. Sinzger, C., Plachter, B., Grefte, A., The, T. H., Jahn, G. (1996) Tissue macrophages are infected by human cytomegalovirus in vivo. J. Infect. Dis. 173, 240-245.
48. Stocchi, R., Ward, K. N., Fanin, R., Baccarani, M., Apperley, J. F. (1999) Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica 84, 71-79.
49. Barry, S. M., Johnson, M. A., Janossy, G. (2000) Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited. Bone Marrow Transplant. 26, 591-597.